Please login to the form below

Not currently logged in
Email:
Password:

Neon Therapeutics

This page shows the latest Neon Therapeutics news and features for those working in and with pharma, biotech and healthcare.

BioNTech plans acquisition of Kite’s TCR cell therapy R&D platform

BioNTech plans acquisition of Kite’s TCR cell therapy R&D platform

It also strengthens our presence in the US, building on our successful integration of adoptive T-cell and neoantigen TCR therapies as part of our acquisition of Neon Therapeutics last year,”

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    article – but, as recent experience with Incyte and Nektar Therapeutics has shown, not all new drugs and combinations will succeed. ... Candidates from Neon Therapeutics, Aduro and BioNTech have passed early-stage testing and are now being studied

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • US biotech Translate Bio appoints Daniella Beckman US biotech Translate Bio appoints Daniella Beckman

    Beckman has over 15 years’ of financial and operational experience and she currently provides consulting and interim chief financial officer services for early-stage biotech companies, including Tango Therapeutics and Neon ... Therapeutics. She said:

  • Neon Therapeutics taps Dr Richard Gaynor for R&D leadership role Neon Therapeutics taps Dr Richard Gaynor for R&D leadership role

    Hugh O'Dowd, chief executive officer of Neon Therapeutics said the company was privileged to have Dr Gaynor join its team. ... His knowledge and leadership reinforces Neon Therapeutics' leadership in neoantigen-based immuno-oncology treatments.”.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Spirit, an OPEN Health Company

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....